Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough

Completed · Not applicable

Conditions studied: Respiratory Tract Diseases

In brief

This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.

Key facts

Study ID

NCT00743990

Run by

Penn State University

People needed

143

Starts

2008-10-01

Expected to finish

2010-03-01

Last updated by the study team

2017-11-24

Who can join

Age: 2 and older, up to 11. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Cough and congestion attributed to upper respiratory tract infection

You may not qualify if…

• Children with signs or symptoms of more serious or treatable disease
• Presence of itchy, watery eyes or frequent sneezing
• Tachypnea (respiratory rate >95%ile) or labored breathing
• Symptoms for 8 or more days
• History of asthma in the past 2 years, chronic lung disease, or seizure disorder
• History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components

Where it is running

• Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.